Cite
APA Citation
Weiss, K. H., Schilsky, M., Czlonkowska, A., Askari, F., Ala, A., Ferenci, P., Ott, P., Abdurakhmanov, D., Szalay, F., Socha, P., Shimizu, N., Bronstein, J., Bega, D., Hahn, S., Swenson, E. S., Chen, Y., & Poujois, A. (n.d.). o01 Efficacy and safety of ALXN1840 versus standard of care in Wilson disease: primary results from an ongoing phase 3, randomized, controlled, rater-blinded trial. Gut, 71, A1. http://access.bl.uk/ark:/81055/vdc_100167535940.0x000015